On Demand: Enhancing Investor Confidence with Robust Biostatistics.
This webinar explores how robust biostatistics is pivotal in investment decisions for biotechs. We’ll discuss strategies to leverage data-driven insights to build investor confidence to secure the financial backing needed for growth and innovation. Whether your biotech organisation is seeking investment or aiming to strengthen investor confidence, this session will provide the secret sauce for early-stage funding.
“As an investor, one of the first things I look for in a biotech company is the relationship between the CMO and the statistician. If they can’t demonstrate a strong, collaborative partnership, then that’s a red flag”. Victoria Manax-Rutson MD, Partner at Eckuity Capital
The webinar is broken down into 3 key discussion topics; What Investors Look For– The Role of Data and Confidence, The Role of Biostatistics in De-Risking Early-Stage Biotech Investments & Biosimulation and its Impact on Investment Decisions. Together our panel highlight key points from both investment and biotech perspectives on how important Biostatistics and Biosimulation plays to investment decisions.
A little about the Host, Company and Speakers
Our esteemed panel features Exploristics CEO Aiden Flynn, Non-Executive Director Susan Clement Davies, and Victoria Manax Rutson, MD, Partner at Eckuity Capital. Together, they bring decades of combined expertise in biotech, medical research, and investment, offering valuable knowledge from their extensive industry experience on successful biotech funding.